StageZero Life Sciences Ltd (NASDAQ:SZLSF) | WebDisclosure

Basculer en Français

8296	Companies
114899	Keywords
55318	Articles
62453	Press releases

Headlines Articles Press releases StageZero Life Sciences Ltd

Home
Companies
StageZero Life Sciences Ltd

BRIEF

published on 05/17/2024 at 22:35, 6 months 3 days ago

StageZero Life Sciences Reports Q1 2024 Financial Performance and Operational Highlights

Financial Results Cancer Diagnostics Q1 2024 Operational Highlights StageZero Life Sciences
PRESS RELEASE

published on 05/17/2024 at 22:30, 6 months 3 days ago

StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
StageZero Life Sciences releases Q1 2024 financial results, achieving $0.523 million in cancer testing revenue. The company updates on strategic partnerships and upcoming catalysts for 2024

Financial Results Partnerships StageZero Life Sciences 2024 Catalysts Cancer Testing Revenue
BRIEF

published on 04/05/2024 at 14:00, 7 months 15 days ago

StageZero Life Sciences annonce le refus de l'OSC de la demande MCTO

OSC Ordonnance D’interdiction D’opérations Par La Direction Sciences De La Vie StageZero Test D'Aristote Programmes De Télésanté
BRIEF

published on 04/05/2024 at 14:00, 7 months 15 days ago

StageZero Life Sciences Announces OSC Denial of MCTO Application

Management Cease Trade Order OSC StageZero Life Sciences Aristotle Test Telehealth Programs
PRESS RELEASE

published on 04/05/2024 at 13:55, 7 months 15 days ago

StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
StageZero Life Sciences announces denial of voluntary management cease trade order application by the Ontario Securities Commission due to anticipated delay in filing financial statements for December 31, 2023

Financial Statements Ontario Securities Commission Delay StageZero Life Sciences Voluntary Management Cease Trade Order
BRIEF

published on 04/03/2024 at 03:35, 7 months 18 days ago

StageZero Life Sciences annonce un retard dans ses résultats financiers du quatrième trimestre et de fin d'année 2023

Résultats Financiers 2023 Ordonnance D’interdiction D’opérations Par La Direction Sciences De La Vie StageZero Retard Financier Outil De Diagnostic D'Aristote
BRIEF

published on 04/03/2024 at 03:35, 7 months 18 days ago

StageZero Life Sciences Announces Delay in Q4 and Year End 2023 Financial Results

Management Cease Trade Order 2023 Financial Results StageZero Life Sciences Financial Delay Aristotle Diagnostic Tool
PRESS RELEASE

published on 04/03/2024 at 03:30, 7 months 18 days ago

StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
StageZero Life Sciences, Ltd. announces a delay in filing its audited financial statements for 2023, cites financial resource constraints. Company applies for Management Cease Trade Order from Ontario Securities Commission

Financial Statements Management Cease Trade Order Ontario Securities Commission Delay StageZero Life Sciences
PRESS RELEASE

published on 11/14/2023 at 17:20, 1 year ago

StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
PRESS RELEASE

published on 11/07/2023 at 13:55, 1 year ago

StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings

Accesswire

Published on 11/21/2024 at 13:00, 18 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 18 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 18 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 18 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 18 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 43 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 3 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 11 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 18 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 48 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 10 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 58 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE